These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32339707)

  • 1. The effect of intradermal botulinum toxin on androgenetic alopecia and its possible mechanism.
    Shon U; Kim MH; Lee DY; Kim SH; Park BC
    J Am Acad Dermatol; 2020 Dec; 83(6):1838-1839. PubMed ID: 32339707
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectiveness and Safety of Botulinum Toxin Type A in the Treatment of Androgenetic Alopecia.
    Zhou Y; Yu S; Zhao J; Feng X; Zhang M; Zhao Z
    Biomed Res Int; 2020; 2020():1501893. PubMed ID: 32802833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The topical penta-peptide Gly-Pro-Ile-Gly-Ser increases the proportion of thick hair in Japanese men with androgenetic alopecia.
    Iwabuchi T; Takeda S; Yamanishi H; Ideta R; Ehama R; Tsuruda A; Shibata H; Ito T; Komatsu N; Terai K; Oka S
    J Cosmet Dermatol; 2016 Jun; 15(2):176-84. PubMed ID: 27030543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perifollicular fibrosis: pathogenetic role in androgenetic alopecia.
    Yoo HG; Kim JS; Lee SR; Pyo HK; Moon HI; Lee JH; Kwon OS; Chung JH; Kim KH; Eun HC; Cho KH
    Biol Pharm Bull; 2006 Jun; 29(6):1246-50. PubMed ID: 16755026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of action of minoxidil in the treatment of androgenetic alopecia is likely mediated by mitochondrial adenosine triphosphate synthase-induced stem cell differentiation.
    Goren A; Naccarato T; Situm M; Kovacevic M; Lotti T; McCoy J
    J Biol Regul Homeost Agents; 2017; 31(4):1049-1053. PubMed ID: 29254313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of male pattern baldness with botulinum toxin: a pilot study.
    Freund BJ; Schwartz M
    Plast Reconstr Surg; 2010 Nov; 126(5):246e-248e. PubMed ID: 21042071
    [No Abstract]   [Full Text] [Related]  

  • 7. Dihydrotestosterone-inducible IL-6 inhibits elongation of human hair shafts by suppressing matrix cell proliferation and promotes regression of hair follicles in mice.
    Kwack MH; Ahn JS; Kim MK; Kim JC; Sung YK
    J Invest Dermatol; 2012 Jan; 132(1):43-9. PubMed ID: 21881585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment effects of intradermal botulinum toxin type A injection on alopecia areata.
    Cho HR; Lew BL; Lew H; Sim WY
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2175-81. PubMed ID: 21134049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reply to: "The effect of intradermal botulinum toxin on androgenetic alopecia and its possible mechanism".
    Carloni R; Gandolfi S; Postel F; Bertheuil N; Pechevy L
    J Am Acad Dermatol; 2020 Dec; 83(6):e435-e436. PubMed ID: 32738424
    [No Abstract]   [Full Text] [Related]  

  • 10. Author's reply to the comment on: "The effect of intradermal botulinum toxin on androgenetic alopecia and its possible mechanism".
    Park BC; Shon U
    J Am Acad Dermatol; 2020 Dec; 83(6):e437. PubMed ID: 32735971
    [No Abstract]   [Full Text] [Related]  

  • 11. Clascoterone as a novel treatment for androgenetic alopecia.
    Sun HY; Sebaratnam DF
    Clin Exp Dermatol; 2020 Oct; 45(7):913-914. PubMed ID: 32421862
    [No Abstract]   [Full Text] [Related]  

  • 12. Botulinum toxin treatment of cephalalgia alopecia increases substance P and calcitonin gene-related peptide-containing cutaneous nerves in scalp.
    Cutrer FM; Sandroni P; Wendelschafer-Crabb G
    Cephalalgia; 2010 Aug; 30(8):1000-6. PubMed ID: 19732078
    [No Abstract]   [Full Text] [Related]  

  • 13. Androgenetic alopecia: pathogenesis and potential for therapy.
    Ellis JA; Sinclair R; Harrap SB
    Expert Rev Mol Med; 2002 Nov; 4(22):1-11. PubMed ID: 14585162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roxithromycin antagonizes catagen induction in murine and human hair follicles: implication of topical roxithromycin as hair restoration reagent.
    Ito T; Fukamizu H; Ito N; Seo N; Yagi H; Takigawa M; Hashizume H
    Arch Dermatol Res; 2009 Jun; 301(5):347-55. PubMed ID: 18820941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A liposome-based formulation containing equol, dihomo-γ-linolenic acid and propionyl-l-carnitine to prevent and treat hair loss: A prospective investigation.
    Brotzu G; Fadda AM; Manca ML; Manca T; Marongiu F; Campisi M; Consolaro F
    Dermatol Ther; 2019 Jan; 32(1):e12778. PubMed ID: 30371981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of finasteride polymer microspheres for systemic application in androgenic alopecia.
    Kim JH; Na J; Bak DH; Lee BC; Lee E; Choi MJ; Ryu CH; Lee S; Mun SK; Park BC; Kim BJ; Lee HS
    Int J Mol Med; 2019 Jun; 43(6):2409-2419. PubMed ID: 30942390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia.
    Gubelin Harcha W; Barboza Martínez J; Tsai TF; Katsuoka K; Kawashima M; Tsuboi R; Barnes A; Ferron-Brady G; Chetty D
    J Am Acad Dermatol; 2014 Mar; 70(3):489-498.e3. PubMed ID: 24411083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there a therapeutic effect of botulinum toxin on scalp alopecia? Physiopathology and reported cases: A systematic review of the literature.
    Carloni R; Pechevy L; Postel F; Zielinski M; Gandolfi S
    J Plast Reconstr Aesthet Surg; 2020 Dec; 73(12):2210-2216. PubMed ID: 32536461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Androgenetic alopecia. Current aspects of a common phenotype].
    Hanneken S; Ritzmann S; Nöthen MM; Kruse R
    Hautarzt; 2003 Aug; 54(8):703-12. PubMed ID: 12942184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical utility and validity of minoxidil response testing in androgenetic alopecia.
    Goren A; Shapiro J; Roberts J; McCoy J; Desai N; Zarrab Z; Pietrzak A; Lotti T
    Dermatol Ther; 2015; 28(1):13-6. PubMed ID: 25112173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.